Cargando…

539. Prevalence of Symptomatic and Asymptomatic COVID-19 Infection in Pregnant Women and Their Infants in an Urban Hospital

BACKGROUND: COVID-19 is an emerging pathogen that has caused a global pandemic, with New York City as one of its epicenters. Data are still forthcoming if pregnant women are more vulnerable to COVID-19, as they are with influenza. Additionally, it is not known if infants born to COVID-19 positive wo...

Descripción completa

Detalles Bibliográficos
Autores principales: Woods, Krystina L, Gabasan, Angela, Schwing, Deborah, Wagner, Brian, Eiland, Lisa, Camins, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776730/
http://dx.doi.org/10.1093/ofid/ofaa439.733
_version_ 1783630750288969728
author Woods, Krystina L
Gabasan, Angela
Schwing, Deborah
Wagner, Brian
Eiland, Lisa
Camins, Bernard
author_facet Woods, Krystina L
Gabasan, Angela
Schwing, Deborah
Wagner, Brian
Eiland, Lisa
Camins, Bernard
author_sort Woods, Krystina L
collection PubMed
description BACKGROUND: COVID-19 is an emerging pathogen that has caused a global pandemic, with New York City as one of its epicenters. Data are still forthcoming if pregnant women are more vulnerable to COVID-19, as they are with influenza. Additionally, it is not known if infants born to COVID-19 positive women are at risk of being infected at birth. METHODS: In March 2020, our hospital instituted a policy of testing all pregnant women presenting for active labor and scheduled C-section or induction of labor, with a nasopharyngeal swab that was sent for RT-PCR qualitative SARS-CoV-2 assay (Roche Cobas® 6800). Upon birth, infants were also tested, unless the parent did not give consent. We retrospectively reviewed the COVID-19 test results of all pregnant women and their infants, from March 23 through May 31, 2020 using our infection control surveillance system (VigiLanz®). We also reviewed the electronic medical record (EPIC®) for documentation of any symptoms consistent with COVID-19 infection either prior to hospitalization or during the hospital stay. RESULTS: A total of 415 women and 72 infants were tested for SARS-CoV-2. Of the 415 women tested, 41 (9.9%) were positive. Of the 72 infants tested, 2 (2.8%) were positive and concordant with their birth parent. Only 1 (2.4%) of the women who tested positive was symptomatic. The remaining 40 (97.6%) women did not report any symptoms of COVID-19 during labor. Neither of the two positive infants displayed any signs or symptoms of COVID-19. Of the 41 women who were positive, 5 did not consent to have their infant tested. The one symptomatic woman who tested positive for COVID-19 had an infant who tested negative by PCR. CONCLUSION: During the first wave of the COVID-19 pandemic, we found 9.9% (41/415) of pregnant women presenting for labor tested positive for SARS-CoV-2. Among the 41 women who tested positive, only 1 (2.4%) had symptoms on presentation and only 2 newborn infants tested positive. Our data suggests that pregnant women may not be at increased risk for complications from COVID-19 disease and are not likely to transmit the disease to their infants during labor. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7776730
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77767302021-01-07 539. Prevalence of Symptomatic and Asymptomatic COVID-19 Infection in Pregnant Women and Their Infants in an Urban Hospital Woods, Krystina L Gabasan, Angela Schwing, Deborah Wagner, Brian Eiland, Lisa Camins, Bernard Open Forum Infect Dis Poster Abstracts BACKGROUND: COVID-19 is an emerging pathogen that has caused a global pandemic, with New York City as one of its epicenters. Data are still forthcoming if pregnant women are more vulnerable to COVID-19, as they are with influenza. Additionally, it is not known if infants born to COVID-19 positive women are at risk of being infected at birth. METHODS: In March 2020, our hospital instituted a policy of testing all pregnant women presenting for active labor and scheduled C-section or induction of labor, with a nasopharyngeal swab that was sent for RT-PCR qualitative SARS-CoV-2 assay (Roche Cobas® 6800). Upon birth, infants were also tested, unless the parent did not give consent. We retrospectively reviewed the COVID-19 test results of all pregnant women and their infants, from March 23 through May 31, 2020 using our infection control surveillance system (VigiLanz®). We also reviewed the electronic medical record (EPIC®) for documentation of any symptoms consistent with COVID-19 infection either prior to hospitalization or during the hospital stay. RESULTS: A total of 415 women and 72 infants were tested for SARS-CoV-2. Of the 415 women tested, 41 (9.9%) were positive. Of the 72 infants tested, 2 (2.8%) were positive and concordant with their birth parent. Only 1 (2.4%) of the women who tested positive was symptomatic. The remaining 40 (97.6%) women did not report any symptoms of COVID-19 during labor. Neither of the two positive infants displayed any signs or symptoms of COVID-19. Of the 41 women who were positive, 5 did not consent to have their infant tested. The one symptomatic woman who tested positive for COVID-19 had an infant who tested negative by PCR. CONCLUSION: During the first wave of the COVID-19 pandemic, we found 9.9% (41/415) of pregnant women presenting for labor tested positive for SARS-CoV-2. Among the 41 women who tested positive, only 1 (2.4%) had symptoms on presentation and only 2 newborn infants tested positive. Our data suggests that pregnant women may not be at increased risk for complications from COVID-19 disease and are not likely to transmit the disease to their infants during labor. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7776730/ http://dx.doi.org/10.1093/ofid/ofaa439.733 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Woods, Krystina L
Gabasan, Angela
Schwing, Deborah
Wagner, Brian
Eiland, Lisa
Camins, Bernard
539. Prevalence of Symptomatic and Asymptomatic COVID-19 Infection in Pregnant Women and Their Infants in an Urban Hospital
title 539. Prevalence of Symptomatic and Asymptomatic COVID-19 Infection in Pregnant Women and Their Infants in an Urban Hospital
title_full 539. Prevalence of Symptomatic and Asymptomatic COVID-19 Infection in Pregnant Women and Their Infants in an Urban Hospital
title_fullStr 539. Prevalence of Symptomatic and Asymptomatic COVID-19 Infection in Pregnant Women and Their Infants in an Urban Hospital
title_full_unstemmed 539. Prevalence of Symptomatic and Asymptomatic COVID-19 Infection in Pregnant Women and Their Infants in an Urban Hospital
title_short 539. Prevalence of Symptomatic and Asymptomatic COVID-19 Infection in Pregnant Women and Their Infants in an Urban Hospital
title_sort 539. prevalence of symptomatic and asymptomatic covid-19 infection in pregnant women and their infants in an urban hospital
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776730/
http://dx.doi.org/10.1093/ofid/ofaa439.733
work_keys_str_mv AT woodskrystinal 539prevalenceofsymptomaticandasymptomaticcovid19infectioninpregnantwomenandtheirinfantsinanurbanhospital
AT gabasanangela 539prevalenceofsymptomaticandasymptomaticcovid19infectioninpregnantwomenandtheirinfantsinanurbanhospital
AT schwingdeborah 539prevalenceofsymptomaticandasymptomaticcovid19infectioninpregnantwomenandtheirinfantsinanurbanhospital
AT wagnerbrian 539prevalenceofsymptomaticandasymptomaticcovid19infectioninpregnantwomenandtheirinfantsinanurbanhospital
AT eilandlisa 539prevalenceofsymptomaticandasymptomaticcovid19infectioninpregnantwomenandtheirinfantsinanurbanhospital
AT caminsbernard 539prevalenceofsymptomaticandasymptomaticcovid19infectioninpregnantwomenandtheirinfantsinanurbanhospital